DeutschNewstral
Sandoz Inc
Astellas Pharma Inc. v. Sandoz Inc. Myrbetriq® (Mirabegron)jdsupra.com- Amgen Inc. v. Sandoz Inc. Otezla® (Apremilast)jdsupra.com
- Amgen Inc. v. Sandoz Inc, No. 2022-1147 (Fed. Cir. Apr. 19, 2023)jdsupra.com
- Breaking Up Is Hard to Do: Validity Upheld Based on Expert Separation Testimonyjdsupra.com
- Federal Circuit Review - December 2022jdsupra.com
- GFilgrastim Market by Type (Lyophilized Powder, Others), Application (Solid Tumor, Lymphoma, Kidney Cancer, Lung Disease, Others), and Geography – Global Trends & Forecasts to 2019-2028galleonnews.com
- Sandoz Inc. V. Amgen Inc. Clears The Way For Potential Earlier Launch Of Biosimilarsjdsupra.com
- Pfizer Inc. v. Sandoz Incjdsupra.com
Court upholds $30 million ruling against SandozDJournalnow- Amgen Inc. v. Sandoz Inc. Federal Circuit Decision on BPCIAjdsupra.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.